Page last updated: 2024-10-22

amifostine anhydrous and Telangiectasis

amifostine anhydrous has been researched along with Telangiectasis in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Telangiectasis: Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.

Research Excerpts

ExcerptRelevanceReference
"Twenty-nine patients with localized prostate cancer were accrued."1.31A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. ( Ben-Josef, E; Biggar, S; Bonner, HS; Han, S; Kaplan, I; Kelly, L; Prokop, S; Shaw, LM; Stamos, B; Tobi, M; Vargas, BJ, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben-Josef, E1
Han, S1
Tobi, M1
Shaw, LM1
Bonner, HS1
Vargas, BJ1
Prokop, S1
Stamos, B1
Kelly, L1
Biggar, S1
Kaplan, I1

Other Studies

1 other study available for amifostine anhydrous and Telangiectasis

ArticleYear
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury.
    International journal of radiation oncology, biology, physics, 2002, Aug-01, Volume: 53, Issue:5

    Topics: Adenocarcinoma; Administration, Topical; Amifostine; Analysis of Variance; Dose-Response Relationshi

2002